January 23, 2012 — Under the terms of a DMAA class action settlement, USPLabs has agreed to pay $2 million to compensate customers who purchased OxyElite Pro and/or Jack3D. The popular pre-workout energy supplements contain DMAA (also known as 1,3-dimethylamylamine or “geranium extract”), which has been linked to serious, life-threatening side effects. USPLabs has not admitted any wrongdoing.
Customers who purchased Jack3D or OxyElite Pro between January 1, 2008 and August 17, 2012 may be eligible for a refund. Individuals who were injured by these products may still be eligible to file a personal injury lawsuit.
The settlement comes after more than a year of criticism that DMAA is not a proper dietary supplement, and USPLabs has made false and misleading statements while marketing the products. The company responded by reformulating their most popular supplement, Jack3D, and re-branding it as “Jack3D Micro” without DMAA, creatine, or beta-alanine.
The company has also been targeted by the U.S. Food and Drug Administration (FDA). In April 2012, the FDA sent 10 manufacturers, including USPLabs, a Warning Letter that stated:
“Synthetically-produced DMAA is not a ‘dietary ingredient’ and, therefore, is not eligible to be used as an active ingredient in a dietary supplement.”
The FDA has also warned that side effects of DMAA include narrowing of the blood vessels, increased blood pressure and heart-rate, shortness of breath, tightness in the chest, heart attack, and death. At least 42 injuries have been linked to DMAA supplements. These injuries include heart problems, psychiatric disorders, central nervous system disorders, and death.
Although DMAA is not currently banned by the U.S. government, sales of DMAA products have been banned on American military bases. It is also banned by most major sports associations and in several European countries.
Do I have a DMAA Lawsuit?
The Schmidt Firm, PLLC is currently accepting DMAA induced injury cases in all 50 states. If you or somebody you know has been injured by DMAA side effects, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.